To hear about similar clinical trials, please enter your email below
Trial Title:
Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma
NCT ID:
NCT05736991
Condition:
Lung Adenocarcinoma
Radiomics
Grading System
Conditions: Official terms:
Adenocarcinoma
Adenocarcinoma of Lung
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
PET/CT-based Radiomics Signature
Description:
Radiomics Signature Based on PET-CT for Predicting the Novel Grading System of Clinical
Stage I Lung Adenocarcinoma
Summary:
The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning
signature for predicting the grade 3 tumors based on the novel grading system in clinical
stage stage I lung adenocarcinoma based on a multicenter prospective cohort.
Criteria for eligibility:
Study pop:
Clinical Stage I Lung Adenocarcinoma
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
(1) Participants scheduled for surgery for radiological finding of pulmonary lesions from
the preoperative thin-section CT scans; (2) The maximum diameter of lesion less than 4 cm
on CT scans; (3) The maximum short axis diameter of lymph nodes less than 1 cm on CT
scan; (4) The SUVmax of hilar and mediastinal lymph nodes less than 2.5; (5) Pathological
confirmation of primary lung adenocarcinoma; (5) Age ranging from 20-75 years; (6)
Obtained written informed consent.
Exclusion Criteria:
(1) Multiple lung lesions; (2) Poor quality of PET-CT images; (3) Participants with
incomplete clinical information; (4) Mucinous adenocarcinomas; (5) Participants who have
received neoadjuvant therapy.
Gender:
All
Minimum age:
20 Years
Maximum age:
75 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Affiliated Hospital of Zunyi Medical University
Address:
City:
Zunyi
Country:
China
Status:
Recruiting
Contact:
Last name:
Yongxiang Song, Dr
Phone:
15505177258
Email:
zhong961008@163.com
Facility:
Name:
The First Affiliated Hospital of Nanchang University
Address:
City:
Nanchang
Country:
China
Status:
Recruiting
Contact:
Last name:
Bentong Yu, Dr
Phone:
15505177258
Email:
bentongyunanchang@163.com
Facility:
Name:
Shanghai Pulmonary Hospital
Address:
City:
Yangpu
Country:
China
Status:
Recruiting
Contact:
Last name:
Chang Chen, MD, PhD
Phone:
+86-021-65115006
Phone ext:
2074
Email:
chenthoracic@163.com
Facility:
Name:
Ningbo HwaMei Hospital
Address:
City:
Ningbo
Country:
China
Status:
Recruiting
Contact:
Last name:
Minglei Yang, Dr
Phone:
1555177258
Email:
ymlsph@163.com
Start date:
November 1, 2022
Completion date:
April 30, 2023
Lead sponsor:
Agency:
Shanghai Pulmonary Hospital, Shanghai, China
Agency class:
Other
Collaborator:
Agency:
Ningbo No.2 Hospital
Agency class:
Other
Collaborator:
Agency:
Zunyi Medical College
Agency class:
Other
Collaborator:
Agency:
The First Affiliated Hospital of Nanchang University
Agency class:
Other
Source:
Shanghai Pulmonary Hospital, Shanghai, China
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05736991
